Open access · US-GOV via ClinicalTrials.gov Clinical trial

METformin And Longevity (METAL): A Window of Opportunity Study Investigating Biological Effects of Metformin in Localised Prostate Cancer

Authors not listed

Guy's and St Thomas' NHS Foundation Trust · 2015

Dysbiosis Metformin Human Randomized controlled trial

Abstract

This is a randomized, placebo-controlled, double-blind, window of opportunity study investigating the biological mechanism of metformin in prostate cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2015). METformin And Longevity (METAL): A Window of Opportunity Study Investigating Biological Effects of Metformin in Localised Prostate Cancer. <em>Guy's and St Thomas' NHS Foundation Trust</em>. https://clinicaltrials.gov/study/NCT02511665

Vancouver

Anonymous. METformin And Longevity (METAL): A Window of Opportunity Study Investigating Biological Effects of Metformin in Localised Prostate Cancer. Guy's and St Thomas' NHS Foundation Trust. 2015.

BibTeX

@misc{anon2015METfor, title = {METformin And Longevity (METAL): A Window of Opportunity Study Investigating Biological Effects of Metformin in Localised Prostate Cancer}, author = {Anonymous}, journal = {Guy's and St Thomas' NHS Foundation Trust}, year = {2015}, }